Autobio Diagnostics Co., Ltd. (603658.SS)
CNY 44.66
(-3.17%)
CNY 44.66
(-3.17%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.52 Billion CNY | 7.17% |
| 2022 | 1.42 Billion CNY | 14.58% |
| 2021 | 1.24 Billion CNY | 35.0% |
| 2020 | 920.39 Million CNY | 6.58% |
| 2019 | 863.59 Million CNY | 37.81% |
| 2018 | 626.65 Million CNY | 39.16% |
| 2017 | 450.32 Million CNY | 43.53% |
| 2016 | 313.74 Million CNY | 48.81% |
| 2015 | 210.84 Million CNY | 18.43% |
| 2014 | 178.02 Million CNY | 16.98% |
| 2013 | 152.18 Million CNY | 27.04% |
| 2012 | 119.79 Million CNY | 44.29% |
| 2011 | 83.02 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 408.89 Million CNY | 0.32% |
| 2024 Q1 | 377.63 Million CNY | -14.52% |
| 2024 Q2 | 407.2 Million CNY | 7.83% |
| 2023 Q3 | 368.06 Million CNY | -4.83% |
| 2023 Q4 | 441.77 Million CNY | 20.02% |
| 2023 Q1 | 367.75 Million CNY | -13.81% |
| 2023 FY | 1.52 Billion CNY | 7.17% |
| 2023 Q2 | 386.73 Million CNY | 5.16% |
| 2022 Q4 | 426.66 Million CNY | 20.9% |
| 2022 Q3 | 352.91 Million CNY | 15.53% |
| 2022 Q1 | 338.63 Million CNY | -11.66% |
| 2022 FY | 1.42 Billion CNY | 14.58% |
| 2022 Q2 | 305.48 Million CNY | -9.79% |
| 2021 Q3 | 267.78 Million CNY | -7.81% |
| 2021 FY | 1.24 Billion CNY | 35.0% |
| 2021 Q1 | 300.96 Million CNY | 1.77% |
| 2021 Q2 | 290.45 Million CNY | -3.49% |
| 2021 Q4 | 383.32 Million CNY | 43.15% |
| 2020 Q3 | 230.8 Million CNY | 24.83% |
| 2020 FY | 920.39 Million CNY | 6.58% |
| 2020 Q1 | 208.97 Million CNY | -16.97% |
| 2020 Q2 | 184.89 Million CNY | -11.52% |
| 2020 Q4 | 295.72 Million CNY | 28.13% |
| 2019 Q3 | 222.78 Million CNY | 28.89% |
| 2019 Q2 | 172.85 Million CNY | -20.08% |
| 2019 FY | 863.59 Million CNY | 37.81% |
| 2019 Q4 | 251.67 Million CNY | 12.97% |
| 2019 Q1 | 216.27 Million CNY | 13.35% |
| 2018 Q3 | 152.2 Million CNY | 22.19% |
| 2018 Q4 | 190.8 Million CNY | 25.36% |
| 2018 FY | 626.65 Million CNY | 39.16% |
| 2018 Q1 | 159.07 Million CNY | 13.16% |
| 2018 Q2 | 124.56 Million CNY | -21.69% |
| 2017 Q3 | 106.84 Million CNY | 6.43% |
| 2017 FY | 450.32 Million CNY | 43.53% |
| 2017 Q4 | 140.57 Million CNY | 31.57% |
| 2017 Q1 | 102.51 Million CNY | 4.13% |
| 2017 Q2 | 100.38 Million CNY | -2.07% |
| 2016 Q1 | 79.25 Million CNY | 43.83% |
| 2016 Q3 | 67.56 Million CNY | -1.34% |
| 2016 Q4 | 98.44 Million CNY | 45.7% |
| 2016 Q2 | 68.48 Million CNY | -13.59% |
| 2016 FY | 313.74 Million CNY | 48.81% |
| 2015 Q1 | 60.48 Million CNY | 0.0% |
| 2015 Q3 | 47.77 Million CNY | -21.01% |
| 2015 Q4 | 55.1 Million CNY | 15.33% |
| 2015 FY | 210.84 Million CNY | 18.43% |
| 2015 Q2 | 60.48 Million CNY | 0.0% |
| 2014 FY | 178.02 Million CNY | 16.98% |
| 2013 FY | 152.18 Million CNY | 27.04% |
| 2012 FY | 119.79 Million CNY | 44.29% |
| 2011 FY | 83.02 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 1.78 Billion CNY | 14.52% |
| Joinn Laboratories(China)Co.,Ltd. | 505.68 Million CNY | -201.7% |
| WuXi AppTec Co., Ltd. | 4.73 Billion CNY | 67.811% |
| Thalys Medical Technology Group Inc. | 570.05 Million CNY | -167.633% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 2.35 Billion CNY | 35.225% |
| Chemclin Diagnostics Co., Ltd. | 169.33 Million CNY | -800.993% |